Grisel J E, Farrier D E, Wilson S G, Mogil J S
Department of Psychology, Furman University, Greenville, SC 29613, USA.
Eur J Pharmacol. 1998 Sep 11;357(1):R1-3. doi: 10.1016/s0014-2999(98)00567-6.
The orphanin FQ/nociceptin (OFQ/N) derivative peptide, [Phe1psi(CH2-NH)Gly2] nociceptin-(1-13)-NH2 (Phe(psi)), has been claimed to be both an antagonist and an agonist of the orphan opioid receptor (ORL1) in different in vitro assays. We now report the dose-dependent inhibition of morphine analgesia by Phe(psi) in mice, an effect parallel to that of OFQ/N. Further, the anti-opioid actions of OFQ/N are not blocked by Phe(psi). Thus, Phe(psi) acts as an ORL1 receptor agonist, not an antagonist, in vivo.
孤儿素FQ/痛敏肽(OFQ/N)衍生肽[Phe1ψ(CH2-NH)Gly2]痛敏肽-(1-13)-NH2(Phe(ψ))在不同的体外试验中被认为既是孤儿阿片受体(ORL1)的拮抗剂又是激动剂。我们现在报告Phe(ψ)在小鼠中对吗啡镇痛的剂量依赖性抑制作用,该作用与OFQ/N的作用相似。此外,OFQ/N的抗阿片作用不受Phe(ψ)的阻断。因此,Phe(ψ)在体内作为ORL1受体激动剂而非拮抗剂发挥作用。